Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Ra Capital Management, L.P. reported a 6.90% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Oct 20, 2025 · Filed Oct 27, 2025
Ra Capital Management, L.P. reported a 6.90% stake in Lexeo Therapeutics, Inc., 5,000,000 shares, as a passive investor on Oct 20, 2025. Filed Oct 27, 2025 (Schedule 13G).
- Stake
- 6.90%
- Shares
- 5,000,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 6.90% | 5,000,000 |
| Peter Kolchinsky | 6.90% | 5,000,000 |
| Rajeev Shah | 6.90% | 5,000,000 |
| RA Capital Healthcare Fund, L.P. | 6.90% | 5,000,000 |
Source
Related
- Lexeo Therapeutics, Inc.
- Ra Capital Management, L.P.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026